MYC deregulation sensitizes cancer cells to N-myristoyltransferase inhibition
Cell Reports · 2025-09 · 44 (9) · 116180
DOI: 10.1016/j.celrep.2025.116180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-09. Verfasst von Gregor A Lueg und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Molecular Sciences Research Hub, White City Campus, Imperial College London, 82 Wood Lane, W12 0BZ London, UK; The Francis C…. Hauptthemen laut MEDLINE: Acyltransferases, Proto-Oncogene Proteins c-myc, N-Myc Proto-Oncogene Protein, Enzyme Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Engineering and Physical Sciences Research Council, German Research Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Molecular Sciences Research Hub, White City Campus, Imperial College London, 82 Wood Lane, W12 0BZ London, UK; The Francis Crick Institute, 1 Midland Road, NW1 1AT London, UK.
- Department of Chemistry, Molecular Sciences Research Hub, White City Campus, Imperial College London, 82 Wood Lane, W12 0BZ London, UK; The Francis Crick Institute, 1 Midland Road, NW1 1AT London, UK; Division of Clinic…
- Myricx Pharma Limited, London Innovation Centre, 20 Water Street, E14 5GX London, UK.
- Department of Chemistry, Molecular Sciences Research Hub, White City Campus, Imperial College London, 82 Wood Lane, W12 0BZ London, UK; Myricx Pharma Limited, London Innovation Centre, 20 Water Street, E14 5GX London, U…
- Department of Chemistry, Molecular Sciences Research Hub, White City Campus, Imperial College London, 82 Wood Lane, W12 0BZ London, UK.
- Division of Clinical Studies, The Institute of Cancer Research (ICR) & Royal Marsden NHS Trust, SW3 6JB London, UK.
Förderung
- Cancer Research UK
- Engineering and Physical Sciences Research Council
- German Research Foundation
- Medical Research Council
- The Francis Crick Institute
- Medicines for Malaria Venture
- Imperial College London
- Wellcome Trust
Zitieren
APA
Lueg, G. A., Zhang, J., Faronato, M., Gorelik, A., Kallemeijn, W. W., Falciani, F., Walton, J., Houghton, J. W., Vannini, S., Poon, E., Costa, B. M., Solari, R., Carr, R., Bell, A. S., Bartlett, E. J., Brzezicha, B., Janz, M., Chesler, L., Calado, D. P., & Tate, E. W. (2025). MYC deregulation sensitizes cancer cells to N-myristoyltransferase inhibition. Cell Reports, 44(9), 116180. https://doi.org/10.1016/j.celrep.2025.116180
Vancouver
Lueg GA, Zhang J, Faronato M, Gorelik A, Kallemeijn WW, Falciani F, et al. MYC deregulation sensitizes cancer cells to N-myristoyltransferase inhibition. Cell Reports. 2025;44(9):116180. doi:10.1016/j.celrep.2025.116180
BibTeX
@article{Lueg2025,
author = {Lueg, Gregor A and Zhang, James and Faronato, Monica and Gorelik, Andrii and Kallemeijn, Wouter W and Falciani, Francesco and Walton, Josephine and Houghton, Jack W and Vannini, Silvia and Poon, Evon and Costa, Barbara M and Solari, Roberto and Carr, Robin and Bell, Andrew S and Bartlett, Edward J and Brzezicha, Bernadette and Janz, Martin and Chesler, Louis and Calado, Dinis P and Tate, Edward W},
title = {MYC deregulation sensitizes cancer cells to N-myristoyltransferase inhibition},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {9},
pages = {116180},
doi = {10.1016/j.celrep.2025.116180}
}
EUVIMED